ribavirin has been researched along with squalene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abrignani, S; Almasio, P; Ascione, A; Bonino, F; Brunetto, MR; Colombatto, P; Houghton, M; Maina, AM; Mondelli, M; Muratori, L; Pinzello, G; Rappuoli, R; Romagnoli, V; Rosa, D; Rumi, MG | 1 |
1 trial(s) available for ribavirin and squalene
Article | Year |
---|---|
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial.
Topics: Adjuvants, Immunologic; Antibodies, Neutralizing; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Proliferation; Combined Modality Therapy; Drug-Related Side Effects and Adverse Reactions; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Injections, Intramuscular; Interferon-alpha; Polyethylene Glycols; Polysorbates; Recombinant Proteins; Ribavirin; RNA, Viral; Squalene; Treatment Outcome; Vaccines, Synthetic; Viral Hepatitis Vaccines; Viral Load | 2014 |